The combined influence of oral contraceptives and human papillomavirus virus on cutaneous squamous cell carcinoma

7Citations
Citations of this article
67Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

The vast majority of cutaneous squamous cell carcinoma (CSCC) will occur in those with fair complexion, tendency to burn, and high ultraviolet radiation (UVR) exposure. Organ transplant recipients also are an important population at great risk for CSCC. An association has been reported between oral contraceptive (OC) use, human papillomavirus virus (HPV) and cervical cancer, and there could be a similar association for CSCC. The cutaneous HPV β-E6 protein, a close cousin of the transformative E6 protein underlying anogenital cancers, has been shown to inhibit apoptosis in response to UVR damage and stimulate morphologic transformation in rodent fibroblast cell lines. Furthermore, OC use has been shown to enhance HPV transcription and may contribute to CSCC risk through this pathway. © the author(s), publisher and licensee Libertas Academica Ltd.

Cite

CITATION STYLE

APA

Efird, J. T., Toland, A. E., Lea, C. S., & Phillips, C. J. (2011). The combined influence of oral contraceptives and human papillomavirus virus on cutaneous squamous cell carcinoma. Clinical Medicine Insights: Oncology. Libertas Academica Ltd. https://doi.org/10.4137/CMO.S6905

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free